Jen-liang L. Su

Taitung, TNQ, Taiwan

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 34 publications

Correction: Deacetylation of HSPA5 by HDAC6 leads to GP78-mediated HSPA5 ubiquitination at K447 and suppresses metastasis of breast cancer.

Correction: Deacetylation of HSPA5 by HDAC6 leads to GP78-mediated HSPA5 ubiquitination at K447 and suppresses metastasis of breast cancer.

Journal: Oncogene
Published: September 21, 2019

Retraction: Knockdown of Contactin-1 Expression Suppresses Invasion and Metastasis of Lung Adenocarcinoma.

Retraction: Knockdown of Contactin-1 Expression Suppresses Invasion and Metastasis of Lung Adenocarcinoma.

Journal: Cancer research
Published: July 17, 2019

Editor's Note: A Novel Peptide Specifically Binding to Interleukin-6 Receptor (gp80) Inhibits Angiogenesis and Tumor Growth.

Editor's Note: A Novel Peptide Specifically Binding to Interleukin-6 Receptor (gp80) Inhibits Angiogenesis and Tumor Growth.

Journal: Cancer research
Published: July 17, 2019

Correction: Amphiregulin enhances alpha6beta1 integrin expression and cell motility in human chondrosarcoma cells through Ras/Raf/MEK/ERK/AP-1 pathway.

Correction: Amphiregulin enhances alpha6beta1 integrin expression and cell motility in human chondrosarcoma cells through Ras/Raf/MEK/ERK/AP-1 pathway.

Journal: Oncotarget
Published: April 28, 2017

miR-107 promotes tumor progression by targeting the let-7 microRNA in mice and humans.

miR-107 promotes tumor progression by targeting the let-7 microRNA in mice and humans.

Journal: The Journal of clinical investigation
Published: March 02, 2017

Erratum to: E1A-Mediated Inhibition of HSPA5 Suppresses Cell Migration and Invasion in Triple-Negative Breast Cancer.

Erratum to: E1A-Mediated Inhibition of HSPA5 Suppresses Cell Migration and Invasion in Triple-Negative Breast Cancer.

Journal: Annals of surgical oncology
Published: February 05, 2017

Angiopoietin-like protein 1 suppresses SLUG to inhibit cancer cell motility.

Angiopoietin-like protein 1 suppresses SLUG to inhibit cancer cell motility.

Journal: The Journal of clinical investigation
Published: January 04, 2017

Targeting the VEGF-C/VEGFR3 axis suppresses Slug-mediated cancer metastasis and stemness via inhibition of KRAS/YAP1 signaling.

Targeting the VEGF-C/VEGFR3 axis suppresses Slug-mediated cancer metastasis and stemness via inhibition of KRAS/YAP1 signaling.

Journal: Oncotarget
Published: August 08, 2016

A novel application of E1A in combination therapy with EGFR-TKI treatment in breast cancer.

A novel application of E1A in combination therapy with EGFR-TKI treatment in breast cancer.

Journal: Oncotarget
Published: May 04, 2016

The STAT3-miRNA-92-Wnt Signaling Pathway Regulates Spheroid Formation and Malignant Progression in Ovarian Cancer.

The STAT3-miRNA-92-Wnt Signaling Pathway Regulates Spheroid Formation and Malignant Progression in Ovarian Cancer.

Journal: Cancer research
Published: April 29, 2016

NF-κB-driven suppression of FOXO3a contributes to EGFR mutation-independent gefitinib resistance.

NF-κB-driven suppression of FOXO3a contributes to EGFR mutation-independent gefitinib resistance.

Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: April 20, 2016

Angiopoietin-like protein 1 antagonizes MET receptor activity to repress sorafenib resistance and cancer stemness in hepatocellular carcinoma.

Angiopoietin-like protein 1 antagonizes MET receptor activity to repress sorafenib resistance and cancer stemness in hepatocellular carcinoma.

Journal: Hepatology (Baltimore, Md.)
Published: March 03, 2016
Showing 1-12 of 34

Last Updated: 09/26/2026